First minimally invasive coronary artery bypass achieved

For high-risk patients, the method could offer a safer alternative to open-heart surgery.
PharmiWeb

Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer

The collaborative clinical study will evaluate ADSTILADRIN® (nadofaragene firadenovec-vncg) in combination with the investigational drug Ruvidar® (TLD-1433) in patients with Bacillus ...
Sierra Sun Times

Researchers Achieve the First Minimally Invasive Coronary Artery Bypass, National Institutes of Health Reports

January 8, 2026 – National Institutes of Health (NIH) released the following: ...

Dip in vector-borne diseases in Maha in 2025; malaria shows slight increase

In 2025, the state reported 14,159 dengue cases and 21 deaths due to dengue, down from 19,385 dengue cases and 40 dengue ...
Daily Excelsior

Technology must be guided by compassion for inclusive development: UP CM Yogi

Uttar Pradesh Chief Minister Yogi Adityanath emphasised on Monday that development becomes truly inclusive and the future ...

Encoded Therapeutics Announces U.S. FDA Breakthrough Therapy Designation Granted to ETX101 for the Treatment of Dravet Syndrome

Encoded Therapeutics, Inc. ("Encoded"), a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, today announced that the U.S. Food and Drug ...

Transgene Publishes Phase I Data Supporting TG4050’s Potential in Preventing Head and Neck Cancer Relapse

TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 ...
PharmiWeb

Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production

Asimov’s LV Edge Packaging cell line routinely achieves high titers for therapeutic transgenes and is now available at AGC Biologics’ Cell and Gene Center of ExcellenceBOSTON & MILAN--(BUSINESS WIRE)- ...